20
Chemwerth Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
One of their notable products is TRIENTINE HYDROCHLORIDE USP, with a corresponding US DMF Number 29019.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 15, 2015, and payment made on September 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II